Gut microbiota and obesity: Role in aetiology and potential therapeutic target
- 1 August 2014
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Gastroenterology
- Vol. 28 (4), 585-597
- https://doi.org/10.1016/j.bpg.2014.07.005
Abstract
No abstract availableFunding Information
- Science Foundation Ireland (12/RC/2273)
- GlaxoSmithKline and Alimentary Health Ltd
This publication has 100 references indexed in Scilit:
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nature Communications, 2013
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic EncephalopathyPLOS ONE, 2013
- Gut microbiota-derived propionate reduces cancer cell proliferation in the liverBritish Journal of Cancer, 2012
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the ratPharmacology Biochemistry and Behavior, 2011
- Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell deathCell Death & Differentiation, 2010
- The endocannabinoid system links gut microbiota to adipogenesisMolecular Systems Biology, 2010
- The dysregulation of the endocannabinoid system in diabesity—a tricky problemJournal of Molecular Medicine, 2009
- Intestinal Alkaline Phosphatase Detoxifies Lipopolysaccharide and Prevents Inflammation in Zebrafish in Response to the Gut MicrobiotaCell Host & Microbe, 2007
- Human gut microbes associated with obesityNature, 2006